Macaques forced to swallow weight-loss drugs in UK labs

A chilling sequence of images reveals the grim reality behind the development of new weight-loss medications: long-tailed macaques are restrained and forced to swallow test drugs via tubes, enduring immense distress in the name of safety. This disturbing footage, secretly captured by a laboratory employee at two facilities in the United Kingdom, was provided exclusively to The Mail on Sunday. The worker described the scenes as horrifying, noting the extreme suffering inflicted on the animals before they could be considered for human use.

The process involves forcing medication into the stomachs of restrained macaques to assess whether the compounds are safe enough to progress to clinical trials with people. However, the worker's account suggests this is not an isolated incident. Beagles, pigs, rabbits, and other species have also been subjected to severe trials for a wide array of new products. These tests are not limited to blockbuster weight-loss drugs; they extend to everyday medicines found on pharmacy shelves, including headache tablets, cholesterol-lowering agents, reflux medications, antihistamines, antibiotics, and antidepressants.

According to the source, every animal that survives the initial testing phase is ultimately killed at the conclusion of the process, with their bodies then dissected for further study. These UK testing sites are contracted by major pharmaceutical corporations to fulfill mandatory safety requirements before a drug can move forward to human trials. Despite the harrowing nature of the methods, both locations operate under the strict regulation of the Home Office and claim to be acting entirely within the law.

The primary goal of these invasive procedures is to determine safety margins, track how compounds move through the body, and identify any adverse effects on vital organs. In some instances, masks are strapped over the faces of beagles and monkeys to force them to inhale trial substances. The implications of these practices extend far beyond the laboratory walls, raising profound questions about the ethical cost of medical progress and the potential risks to communities that rely on these life-saving treatments.

A former laboratory employee has sought to bring hidden realities of animal testing into the public eye by releasing footage and details of procedures that caused distress to primates, dogs, pigs, and rabbits. The worker, who was haunted by the shrieks and whimpers heard during trials that could span up to two years, stated that his conscience prevented him from simply quitting. He expressed a hope that exposing this concealed world would spark a necessary change in how society approaches scientific research.

In response to the revelation, campaigners have urged the government to accelerate its commitment to phasing out animal testing, describing the released footage as shocking. Conversely, an animal testing advocacy group defended the current practices, arguing that extreme suffering is rare and that these trials remain essential for developing life-saving medications. They maintain that such testing is vital for establishing safety margins, understanding how compounds move through the body, and assessing the impact on organs before drugs are released for human use.

The specific procedures documented include 'oral gavage,' where a rubber tube is inserted down the throats of restrained animals to deliver substances directly to their stomachs. This method is frequently employed on long-tailed macaques to test treatments for liver diseases and weight-loss drugs, as well as on beagles for anti-inflammatory medications. In other instances, masks are strapped to the faces of beagles and monkeys to force the inhalation of trial substances. Additionally, monkeys are often restrained in vices around their necks and waists, while mini pigs are subjected to treatments involving eight surgical cuts on their backs to test medications for ulcers and skin infections. Pregnant rabbits are also used to evaluate how new drugs affect embryo survival and development, and intravenous tests involve injecting compounds directly into the bloodstream of restrained animals.

The former lab worker revealed that he had no prior knowledge of the toxicity testing regulations until he was hired, noting that the procedures often appear shocking to the general public but are normalized within the industry. He observed that while he and his colleagues cared deeply about the animals, their roles required them to facilitate the animals' suffering. Although the workplace mantra suggested that their work contributed positively to the world, the employee quickly rejected this narrative, questioning how anything good could emerge from such practices. He noted that even when workers played music to distract themselves, the distress and intense suffering of the animals remained impossible to ignore.

The footage shows primates struggling, crying, and screaming to avoid tubes being forced into their mouths, and recalls the loud squealing of mini pigs during various procedures. The worker described the moment of killing the animals at the end of a trial as devastating for the staff, noting that while it was intended to end the suffering, it still felt like a final violation. His decision to intervene comes in the wake of guidance issued last month by the US Food and Drug Administration (FDA) encouraging drug developers to seek alternatives to animal testing. The American regulator has promoted a shift toward 'human-centric models' that it claims can more reliably, efficiently, and ethically predict human drug reactions before clinical trials. Last year, the FDA highlighted that over 90 per cent of drugs appearing safe and effective in animals fail to receive approval in humans, often due to safety or efficacy issues, and noted that animal data have been poor predictors for conditions such as cancer, Alzheimer's, and inflammatory diseases.

The Food and Drug Administration recently outlined new strategies to replace animal testing with advanced alternatives. These methods include computer modeling and artificial intelligence to forecast drug behavior. Additionally, the agency plans to utilize lab-grown human organoids and organ-on-a-chip systems. These technologies mimic human liver, heart, and immune organs to assess safety.

Some widely used medications, such as aspirin, may never have undergone animal testing. Conversely, compounds appearing safe in animal models sometimes proved lethal in human trials. This discrepancy highlights the need for more accurate predictive tools in drug development.

However, pro-testing advocacy groups challenge the FDA's claims as a misconception likely to change. They argue that clinical trials show animal data matches human data in 90 percent of cases. Chris Magee from Understanding Animal Research supports this view. He stated that extreme suffering for animals in such tests is very rare.

Magee noted that disturbing footage often highlights the rarest and most severe experiments permitted by law. The FDA issued this guidance last month to assist drug developers in creating these alternatives. The goal is to trial new products while reducing reliance on traditional animal models.

New footage depicting a monkey being restrained before undergoing testing has ignited a fierce debate regarding the ethics and future of animal research in the United Kingdom. Activists have seized upon the video to demand that the Government immediately fast-track its commitment to eliminate animal testing entirely, labeling the imagery as deeply disturbing.

Chris Magee, a representative for Understanding Animal Research, offered a contrasting perspective, asserting that such extreme suffering is exceptionally uncommon in modern research protocols. He noted that the distress captured in the video likely represents the rarest and most severe categories of experiments legally permitted. Magee emphasized that current legislation strictly prohibits the use of animals when non-animal alternatives exist. Furthermore, he clarified that dogs and primates are the least frequently utilized species and are strictly barred from experiments if another animal model can serve as a substitute.

The historical context of these regulations dates back to 1968, when routine animal testing was mandated in the UK following tragedies like the thalidomide scandal, where inadequate pre-market testing resulted in severe harm to human populations. Under existing laws, the use of primates is legally confined to preventing, diagnosing, or treating debilitating or life-threatening conditions in humans. Additionally, any procedure likely to inflict pain, suffering, or distress must be conducted with anesthesia or analgesics, unless administering such medication would fundamentally undermine the scientific objective.

Despite a significant forty-three percent reduction in animals used for regulatory testing over the last decade, Magee warned that a complete cessation of animal testing remains unattainable for the foreseeable future. He explained that current alternatives, such as cell cultures or "organs-on-chips," cannot yet fully replicate the intricate complexity of a living organism. Research requires understanding how substances interact within a whole system, including absorption, distribution, metabolism, and potential transformation into hazardous compounds within the body. These studies also assess environmental impact by analyzing how drugs behave after excretion.

Magee highlighted that many medications available today, including cancer treatments and statins, are life-saving. He added that euthanizing animals after testing is a necessary step, as post-mortem examinations provide the only means to identify the causes and progression of diseases. This scientific reality stands in contrast to the political rhetoric; while the Labour Party pledged to phase out animal testing in its recent election manifesto, Science Minister Lord Vallance stated last year that eliminating all animal testing is not feasible in the near term.

Lyn White, director of Animals International, described the footage as evidence of a broader issue involving weeks or months of repeated dosing, restraint, and confinement rather than isolated incidents. She argued that the suffering depicted is prolonged and cumulative, noting that these experiments have long operated behind closed doors, denying the public a chance to weigh in on whether such pain should continue.

Irene Campbell, a Labour MP and chair of the All-Party Parliamentary Group on Phasing Out Animal Experiments in Medical Research, called for decisive action. She stated that the visible suffering in the video underscores the urgent need to accelerate the transition away from animal experiments. Campbell advocated for the rapid adoption of innovative, human-specific methods, asserting that these new approaches offer the greatest potential for advancing patient care.